study_acronym	Study_internal	Library	Sample	Donor	n_cells	sex	sex_ontology_term_id	age_years	age_range	age_group	development_stage_ontology_term_id	gestational_age_weeks	postmenstrual_age_weeks	weight_kg	bmi	self_reported_ethnicity	self_reported_ethnicity_ontology_term_id	smoking_status	smoking_pack_years	disease	disease_acronym	disease_ontology_term_id	disease_group	disease_detail	cause_of_death	cause_of_death_category	donor_death_type	tissue	tissue_ontology_term_id	anatomic_region	anatomic_region_ontology_term_id	anatomic_region_detail	sampling_method	preservation_method	suspension_type	cell_enrichment	assay	assay_ontology_term_id	ards_severity	ards_dad_group	covid_history	covid_pcr_result	cancer_status	comorbidities	fibrosis_region	fev1_liters	fvc_liters	fev1_percent_predicted	fvc_percent_predicted	fev1_fvc_ratio	dlco_percent_predicted	copd_gold_stage	primary_pathology_diagnosis	secondary_pathology_diagnosis	source_study_title	source_accession	source_repository	source_lungmap_id	source_lungmap_url	source_publication_status	source_publication_title	source_publication_year	source_pmid	source_doi	source_data_url	source_publication_url	source_match_basis
Jaiswal 2026 CellGenom	MGH-ILD	M10_1090438_R1	M10	M10	3939	female	PATO:0000383	52	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		chronic obstructive pulmonary disease	COPD	MONDO:0005002	obstructive lung disease	alpha-1-antitrypsin deficiency; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	alpha-1 antitrypsin deficiency		0.68	2.48			0.274	10				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M10_1090438_R2	M10	M10	4245	female	PATO:0000383	52	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		chronic obstructive pulmonary disease	COPD	MONDO:0005002	obstructive lung disease	alpha-1-antitrypsin deficiency; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	alpha-1 antitrypsin deficiency		0.68	2.48			0.274	10				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M10_1090487_R1	M10	M10	32	female	PATO:0000383	52	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		chronic obstructive pulmonary disease	COPD	MONDO:0005002	obstructive lung disease	alpha-1-antitrypsin deficiency; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	alpha-1 antitrypsin deficiency		0.68	2.48			0.274	10				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M10_1090487_R2	M10	M10	40	female	PATO:0000383	52	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		chronic obstructive pulmonary disease	COPD	MONDO:0005002	obstructive lung disease	alpha-1-antitrypsin deficiency; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	alpha-1 antitrypsin deficiency		0.68	2.48			0.274	10				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M11_1092560	M11	M11	5996	male	PATO:0000384	49	45-49 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		chronic obstructive pulmonary disease	COPD	MONDO:0005002	obstructive lung disease	alpha-1-antitrypsin deficiency; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	alpha-1 antitrypsin deficiency		2.24	3.39			0.661	40				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M11_1092561	M11	M11	4510	male	PATO:0000384	49	45-49 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		chronic obstructive pulmonary disease	COPD	MONDO:0005002	obstructive lung disease	alpha-1-antitrypsin deficiency; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	alpha-1 antitrypsin deficiency		2.24	3.39			0.661	40				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M12_1111095	M12	M12	7083	female	PATO:0000383	61	60-64 years	adult	HsapDv:0000158					European	HANCESTRO:0005	never		pulmonary hypertension	PH	MONDO:0005149	pulmonary vascular disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			1.9	2.3			0.826	28				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M12_1111099	M12	M12	4010	female	PATO:0000383	61	60-64 years	adult	HsapDv:0000158					European	HANCESTRO:0005	never		pulmonary hypertension	PH	MONDO:0005149	pulmonary vascular disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			1.9	2.3			0.826	28				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M13_1104938	M13	M13	2172	male	PATO:0000384	59	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.84	3.21			0.885	29				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M13_1104950	M13	M13	3675	male	PATO:0000384	59	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.84	3.21			0.885	29				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M15_F_CST	M15	M15	1821	male	PATO:0000384	69	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	never		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.62	3.39			0.773	34				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M15_F_TST	M15	M15	2139	male	PATO:0000384	69	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	never		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.62	3.39			0.773	34				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M15_N_CST	M15	M15	471	male	PATO:0000384	69	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	never		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.62	3.39			0.773	34				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M15_N_TST	M15	M15	1826	male	PATO:0000384	69	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	never		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.62	3.39			0.773	34				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M19_1111034	M19	M19	984	male	PATO:0000384	65	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	former		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			1.56	1.85			0.843	34				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M1_1123764	M1	M1	25	female	PATO:0000383	79	75-79 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	former		normal	healthy	PATO:0000461	normal					lung	UBERON:0002048	lung parenchyma	UBERON:0008946		surgical resection		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer												MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M20_F_TST	M20	M20	5055	male	PATO:0000384	70	70-74 years	older adult	HsapDv:0000161							never		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.25	2.53			0.889	50				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M20_N_CST	M20	M20	9200	male	PATO:0000384	70	70-74 years	older adult	HsapDv:0000161							never		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.25	2.53			0.889	50				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M20_N_TST	M20	M20	6485	male	PATO:0000384	70	70-74 years	older adult	HsapDv:0000161							never		idiopathic pulmonary fibrosis	IPF	MONDO:0800504	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.25	2.53			0.889	50				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M23_1114257	M23	M23	5308	male	PATO:0000384	58	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		hypersensitivity pneumonitis	HP	MONDO:0017853	interstitial/fibrotic lung disease	fibrotic; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.16	3.09			0.699	37				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M23_1114261	M23	M23	1670	male	PATO:0000384	58	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		hypersensitivity pneumonitis	HP	MONDO:0017853	interstitial/fibrotic lung disease	fibrotic; end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.16	3.09			0.699	37				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M25_1104918	M25	M25	4711	female	PATO:0000383	42	40-44 years	adult	HsapDv:0000158					African	HANCESTRO:0010	never		nonspecific interstitial pneumonia	NSIP	MONDO:0019622	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			0.64	0.92			0.696	14				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M25_1104919	M25	M25	4985	female	PATO:0000383	42	40-44 years	adult	HsapDv:0000158					African	HANCESTRO:0010	never		nonspecific interstitial pneumonia	NSIP	MONDO:0019622	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			0.64	0.92			0.696	14				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M26_1113132	M26	M26	3941	female	PATO:0000383	67	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	former		nonspecific interstitial pneumonia	NSIP	MONDO:0019622	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			1.34	1.46			0.918	33				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M26_1113141	M26	M26	4910	female	PATO:0000383	67	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	former		nonspecific interstitial pneumonia	NSIP	MONDO:0019622	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			1.34	1.46			0.918	33				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M27_1111019	M27	M27	4430	male	PATO:0000384	63	60-64 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		rheumatoid arthritis-associated interstitial lung disease	RA-ILD	MONDO:0004586	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	rheumatoid arthritis		2.44	2.91			0.838	50				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M27_1111025	M27	M27	5219	male	PATO:0000384	63	60-64 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		rheumatoid arthritis-associated interstitial lung disease	RA-ILD	MONDO:0004586	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	rheumatoid arthritis		2.44	2.91			0.838	50				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M28_1105845	M28	M28	1630	female	PATO:0000383	53	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		rheumatoid arthritis-associated interstitial lung disease	RA-ILD	MONDO:0004586	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	rheumatoid arthritis		0.74	0.85			0.871					MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M28_1105849_R1	M28	M28	416	female	PATO:0000383	53	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		rheumatoid arthritis-associated interstitial lung disease	RA-ILD	MONDO:0004586	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	rheumatoid arthritis		0.74	0.85			0.871					MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M28_1105849_R2	M28	M28	1417	female	PATO:0000383	53	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		rheumatoid arthritis-associated interstitial lung disease	RA-ILD	MONDO:0004586	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	rheumatoid arthritis		0.74	0.85			0.871					MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M28_1105849_R3	M28	M28	2	female	PATO:0000383	53	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		rheumatoid arthritis-associated interstitial lung disease	RA-ILD	MONDO:0004586	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	rheumatoid arthritis		0.74	0.85			0.871					MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M29_F_TST	M29	M29	3988	male	PATO:0000384	54	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		interstitial pneumonia with autoimmune features	IPAF	MONDO:0015925	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.55	3.19			0.799	60				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M29_N_TST	M29	M29	2920	male	PATO:0000384	54	50-54 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		interstitial pneumonia with autoimmune features	IPAF	MONDO:0015925	interstitial/fibrotic lung disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.55	3.19			0.799	60				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M5_1124615	M5	M5	1854	female	PATO:0000383	73	70-74 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	never		normal	healthy	PATO:0000461	normal					lung	UBERON:0002048	lung parenchyma	UBERON:0008946		surgical resection		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			2.17	2.35			0.923	58				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M7_SN	M7	M7	8398	female	PATO:0000383	68	65-69 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	never		normal	healthy	PATO:0000461	normal					lung	UBERON:0002048	lung parenchyma	UBERON:0008946		surgical resection		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer												MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M8_SN	M8	M8	8190	female	PATO:0000383	78	75-79 years	older adult	HsapDv:0000161					European	HANCESTRO:0005	former		normal	healthy	PATO:0000461	normal					lung	UBERON:0002048	lung parenchyma	UBERON:0008946		surgical resection		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer			1.89	2.7			0.7	62				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M9_1105572_R1	M9	M9	2022	female	PATO:0000383	56	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		pulmonary arterial hypertension	PAH	MONDO:0015924	pulmonary vascular disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	chronic obstructive pulmonary disease		2.05	3.18			0.645	36				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M9_1105572_R2	M9	M9	110	female	PATO:0000383	56	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		pulmonary arterial hypertension	PAH	MONDO:0015924	pulmonary vascular disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	chronic obstructive pulmonary disease		2.05	3.18			0.645	36				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M9_1105576_R1	M9	M9	1528	female	PATO:0000383	56	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		pulmonary arterial hypertension	PAH	MONDO:0015924	pulmonary vascular disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	chronic obstructive pulmonary disease		2.05	3.18			0.645	36				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.
Jaiswal 2026 CellGenom	MGH-ILD	M9_1105576_R2	M9	M9	1970	female	PATO:0000383	56	55-59 years	adult	HsapDv:0000158					European	HANCESTRO:0005	former		pulmonary arterial hypertension	PAH	MONDO:0015924	pulmonary vascular disease	end-stage/advanced				lung	UBERON:0002048	lung parenchyma	UBERON:0008946		lung explant		nucleus	unsorted	10x 3' v3	EFO:0009922					no cancer	chronic obstructive pulmonary disease		2.05	3.18			0.645	36				MGH ILD single-nucleus RNA-seq / Cell Genomics supplementary metadata (mmc2)	Cell Genomics supplementary table mmc2	Cell Genomics			published	Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases	2026	41576947	10.1016/j.xgen.2025.101066	https://doi.org/10.1016/j.xgen.2025.101066	https://pubmed.ncbi.nlm.nih.gov/41576947/	The Study label explicitly identifies the Cell Genomics mmc2 cohort; publication uses single-nucleus RNA-seq plus spatial transcriptomics in MGH ILD.